Honeywell International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-385,000
Closed -$22M – 174
2016
Q1
$22M Buy
385,000
+285,000
+285% +$15.9M 0.55% 81
2015
Q4
$5.92M Buy
+100,000
New +$5.76M 0.15% 140
2015
Q1
– Sell
-428,500
Closed -$28M – 175
2014
Q4
$28M Sell
428,500
-336,500
-44% -$21.2M 0.64% 62
2014
Q3
$44.2M Buy
765,000
+490,000
+178% +$27.2M 1.04% 22
2014
Q2
$15.5M Buy
+275,000
New +$14.4M 0.36% 119

Other funds holding ABBV

Honeywell International's ABBV Position: Q2 2016 in Review

Honeywell International sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 385,000 shares — an estimated $22M sold.

Honeywell International first reported a position in ABBV in Q2 2014 and held it in 5 quarters. The position peaked at $44.2M in Q3 2014. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • Honeywell International reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • Honeywell International sold 385,000 AbbVie shares in Q2 2016, an estimated $22M.
  • Honeywell International first reported a position in AbbVie in Q2 2014 and held it in 5 quarters.
  • Honeywell International's AbbVie position peaked at $44.2M in Q3 2014.
  • 1,636 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on Honeywell International's 13F filing for Q2 2016, filed 8 Aug 2016.